Navigation Links
In Vivo Data on Taligen Therapeutics' Pipeline Candidates Presented at the XXII International Complement Workshop
Date:10/7/2008

CAMBRIDGE, Mass., Oct. 7 /PRNewswire/ -- Taligen Therapeutics Inc. today announced that in vivo data on several of the Company's pipeline candidates were presented at the XXII International Complement Workshop in Basel, Switzerland. The data highlighted the candidates' efficacy in several animal models of complement-mediated diseases.

"These highlighted presentations, as well as several in vitro studies presented at the conference, reveal the deep expertise and expanding knowledge base within the complement research community," said Michael Holers, M.D., chief scientific officer of Taligen Therapeutics. "The work, not only from our laboratory but from the laboratories of our collaborators, is unlocking the mechanisms of immunomodulation and enabling Taligen to direct the development of new product candidates and test them in a variety of animal models as a precursor to their clinical development."

"The opportunity to further evaluate Taligen's TT30 compound in our research activities has been invaluable in our characterization of the effects of modulation of the complement system on animal models of human disease," said Steve Tomlinson, Ph.D. and principal investigator of several studies presented at the complement meeting. "Our results in the MRL lupus model in collaboration with Dr. Gary Gilkeson's group now show that targeted complement inhibition using TT30 leads to both local control of inflammation as well as a substantial decrease in the autoimmune response in vivo. No other type of compound has this dual profile of activity. I also believe these CR2-targeted compounds will help future research in the lupus area and hopefully provide therapeutic options for patients."

Key findings from several of the studies testing Taligen's product candidates are highlighted below:

Data support targeting the alternative complement pathway using TT30 as an immunomodulatory compound for treating complement-mediated diseases

In vivo st
'/>"/>

SOURCE Taligen Therapeutics Inc.
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Data from In Vivo Disease Models on Taligen Therapeutics Pipeline Candidates to be Presented at the XXII International Complement Workshop
2. Taligen Therapeutics Initiates Corporate Growth Plan with Appointment of Abbie Celniker, Ph.D., as CEO and Establishment of Cambridge, Mass., Headquarters
3. BN ImmunoTherapeutics Announces Positive Mature Phase II Results From Newly Acquired Prostate Cancer Vaccine
4. Video: Sirion Therapeutics Launches Durezol for Postoperative Ocular Inflammation and Pain
5. Orexigen(R) Therapeutics Presents Data on Its Proprietary Formulation of Naltrexone Sustained Release (SR) Used in Contrave(R)
6. PTC Therapeutics Announces Data Showing Six-Minute Walk Test Consistently Measures Ambulatory Function in Patients With Duchenne Muscular Dystrophy
7. Data Confirm Synvista Therapeutics Haptoglobin Diagnostic Test Kit Success in Rapidly Determining Cardiovascular Risk in Patients with Diabetes
8. Logical Therapeutics Inc. Commences Double-Blind, Randomized Study of Their Lead Program, LT-NS001
9. Agile Therapeutics Achieves Phase 2 Study Endpoints in Key Clinical Trials with New, Innovative Low-Dose Contraceptive Patch
10. Tobira Therapeutics Inc. Receives US Patent for TBR-652
11. MabVax Therapeutics Closes Two Licensing Agreements With Sloan-Kettering Institute for Cancer Research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/16/2013)... , May 16, 2013 Developers of a ... patient reminders have emerged as grand prize winners in the ... challenge funded by Boehringer Ingelheim and organized by HITLAB ... , John Langhauser and ... from the United States will receive ...
(Date:5/16/2013)... NEW YORK , May 16, 2013 ... biopharmaceutical company that develops innovative targeted payload ... that the official program of TAT: Target ... a presentation devoted to Actinium Pharmaceuticals, clinical ... Acute Myeloid Leukemia with Bismuth-213 and Actinium-225" ...
(Date:5/16/2013)... Fla. , May 16, 2013  Lakewood-Amedex ... announced today that a recent series of ... that its novel class of antimicrobials, named bisphosphocins, ... involving bacterial membrane depolarization, resulting in rapid direct ... experiments demonstrating Nu-3 to be superior to ciprofloxacin.  ...
Breaking Medicine Technology:Wireless Pill Bottle Wins Healthcare Innovation World Cup 2Wireless Pill Bottle Wins Healthcare Innovation World Cup 3Wireless Pill Bottle Wins Healthcare Innovation World Cup 4Wireless Pill Bottle Wins Healthcare Innovation World Cup 5Actinium Pharmaceuticals Clinical Results to be Presented at 8th International Symposium on Targeted Alpha Therapy Conference 2Actinium Pharmaceuticals Clinical Results to be Presented at 8th International Symposium on Targeted Alpha Therapy Conference 3Lakewood-Amedex Announces Results Demonstrating The More Rapid Direct Bactericidal Activity Of Novel Bisphosphocin Class Of Antimicrobials 2Lakewood-Amedex Announces Results Demonstrating The More Rapid Direct Bactericidal Activity Of Novel Bisphosphocin Class Of Antimicrobials 3Lakewood-Amedex Announces Results Demonstrating The More Rapid Direct Bactericidal Activity Of Novel Bisphosphocin Class Of Antimicrobials 4
... N.C., July 20, 2011 Chimerix, Inc., a biotechnology ... Painter, Ph.D., Chairman of the Board and Chief Scientific ... Annual Biodefense Vaccines & Therapeutics Conference on July 22nd, ... at the Almas Temple Club in Washington, D.C. on ...
... July 20, 2011 A new online resource, ... law enforcement, and community organizations combat the illegal diversion ... Pharma L.P . has developed RxSafetyMatters.org to ... organizations with which it is partnering to help deter ...
Cached Medicine Technology:Chimerix to Present at Infocast's 9th Annual Biodefense Vaccines & Therapeutics Conference 2Chimerix to Present at Infocast's 9th Annual Biodefense Vaccines & Therapeutics Conference 3New Online Resource to Help Combat Abuse of Prescription Medications Launched by Purdue Pharma L.P. 2New Online Resource to Help Combat Abuse of Prescription Medications Launched by Purdue Pharma L.P. 3
(Date:5/18/2013)... CA (PRWEB) May 18, 2013 John Ravera, ... announced the addition of a new member to his dental ... has worked in the field for over 10 years. She ... with honors, and was elected a member of Sigma Pi ... hygiene profession. Marino enjoys working with patients of all ages, ...
(Date:5/18/2013)... San Diego, CA (PRWEB) May 18, 2013 ... In its latest update to consumers about ... consolidated in federal court Resource4thePeople reports that ... litigation, according to court documents. , The ... in U.S. District Court in the Southern ...
(Date:5/18/2013)... Vegas, Nevada (PRWEB) May 18, 2013 ... Cambogia Extract weight loss supplement, which features unmatched potency ... , “Creation's Gold was set up to provide the ... as they work to achieve their wellness goals. The ... need to lead happier, healthier lives. We started by ...
(Date:5/17/2013)... May 18, 2013. Chronic trauma can inflict lasting damage ... imaging studies of people with post-traumatic stress disorder, or ... under-react in response to stressful tasks, such as recalling ... a threatening face. Now, researchers at NYU School of ... in the brains of combat veterans with PTSD in ...
(Date:5/17/2013)... Daily Gossip announced on Monday that their reporters ... Program Yourself Thin regime, Jim Katsoulis. , ... the end of the month in order to teach readers ... and lead a healthy lifestyle, free of food cravings and ... is available for only $97 and it comes with six ...
Breaking Medicine News(10 mins):Health News:Newport Beach Cosmetic Dentist John Ravera Adds New Member to Dental Team 2Health News:2013 Alleged Transvaginal Mesh Complications Lawsuits Update: Resource4thePeople Reports Defendants Ordered to Provide Testimony, Documents 2Health News:2013 Alleged Transvaginal Mesh Complications Lawsuits Update: Resource4thePeople Reports Defendants Ordered to Provide Testimony, Documents 3Health News:2013 Alleged Transvaginal Mesh Complications Lawsuits Update: Resource4thePeople Reports Defendants Ordered to Provide Testimony, Documents 4Health News:Creation's Gold Launches Potent Garcinia Cambogia Supplement for Weight Loss 2Health News:For combat veterans suffering from post-traumatic stress disorder, 'fear circuitry' in the brain never rests 2Health News:Program Yourself Thin Review and Secrets Revealed By Daily Gossip Magazine 2
... and choose certain brands, experts note , , THURSDAY, ... reaching teenagers and influencing their desire to smoke and ... "We are continuing to find that Marlboro, Newport and ... to be overwhelmingly the preferred brands of cigarettes smoked ...
... With the goal of advancing the lives,of children and ... Ski and Snowboard Program hit the slopes last weekend. ... on,Saturday, Feb. 7, for a day of fun, competition ... ski race. , The event, ...
... art of sleep with Sleep Concierge consultation and other Dreamy Perks ... ... of a sleepless night - jet-lag, a new baby, a plummeting portfolio ... National Sleep Foundation, costs companies more than $100 billion annually in reduced ...
... 12 /PRNewswire-USNewswire/ - - A new report on ... students demonstrates the need for Congress to give the ... tobacco, Partnership for Prevention Interim President Corinne G. Husten, ... brand of cigarettes in history is also the favorite ...
... Feb. 12 Today, the Medicaid Health Plans ... focused on representing Medicaid health plans, applauded House and ... American Recovery and Reinvestment Act Conference Report that will ... "The Medicaid provisions in this agreement will allow states ...
... released today by Every Child By Two:The U.S. Court ... over the causes of autism. The three judges ... with thimerosal-containing vaccines, does not cause autism. The ... have failed to show a link between vaccines and ...
Cached Medicine News:Health News:Tobacco Companies Targeting Teens, Study Says 2Health News:Tobacco Companies Targeting Teens, Study Says 3Health News:Tobacco Companies Targeting Teens, Study Says 4Health News:Second Annual Courage Cup Race Raises More Than $5,000 for Courage Center's Ski and Snowboard Program 2Health News:The Benjamin Marks National Sleep Awareness Week With Introduction Of "The Sleep Retreat" 2Health News:The Benjamin Marks National Sleep Awareness Week With Introduction Of "The Sleep Retreat" 3Health News:Partnership for Prevention: CDC Report Shows Compelling Need for FDA Regulation of Tobacco 2Health News:Medicaid Health Plans of America Lauds Stimulus Bill's Conference Agreement Which Provides $90 Billion in Medicaid Relief for Nation's Most Vulnerable Citizens 2Health News:Federal Court Declares Vaccines Do Not Cause Autism 2
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: